By Sky News –
It is likely to be the first licensed treatment to slow Huntington’s, and that “changes everything”, says lead investigator Professor Ed Wild.
Known as AMT-130, it is delivered via brain surgery, and a single dose is expected to last someone’s whole life.
“This result changes everything,” said principal investigator Professor Ed Wild.
Thirty-year-old Jack May-Davis, who took part in trials, said the results were “astonishing”, leaving him “lost for words”.
Huntington’s is a neurodegenerative disease which gets worse over time and has no cure, affecting thinking, movement and mood. About 8,000 people in the UK suffer from it.
